First Trust NYSE Arca Biotechnology Index Fund (FBT)

119.62
Delayed Data
As of Mar 27
 +3.16 / +2.71%
Today’s Change
67.27
Today|||52-Week Range
128.19
+17.25%
Year-to-Date
FBT Regular Dividend: FBT began trading ex-dividend on 03/25/15. A $0.0476 dividend will be paid to shareholders of record as of 03/27/15.

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE Arca Biotechnology Index(SM). The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in common stocks that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. The fund is non-diversified.

Performance

1 month+0.40% 3 years+41.94%
3 months+12.72% 5 years+25.36%
1 year+53.32% Since inception+22.44%
Data through 03/27/2015

Quote Details

Previous close$116.46
Open day’s range117.17 – 120.05
Net asset value (NAV)116.52 (03/26/2015)
Daily volume217,316
Average volume (3 months)246,860
Data as of 3:59pm ET, 03/27/2015

Peer Comparisonvs. Health ETFs

 FBTCategory
Performance 5-yr return+25.36%+22.29%
Expense Gross exp ratio0.61%0.47%
Risk 5 year sharpe ratio1.221.51
Net assets$2.9B$1.7B
Average market cap$9.5B$32.9B
Average P/E24.926.3
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
PCYC Pharmacyclics Inc4.61%
ICPT Intercept Pharmaceuticals Inc4.57%
NVAX Novavax Inc4.18%
CLDX Celldex Therapeutics Inc3.91%
BIIB Biogen3.61%
INCY Incyte Corp3.59%
SGEN Seattle Genetics Inc3.59%
CRL Charles River Laboratories International Inc3.49%
UTHR United Therapeutics Corp3.42%
Q Quintiles Transnational Holdings Inc3.39%

To view my watchlist

Not a member yet?

Sign up now for a free account